Evidence map›Paper›PMID 36107396›Full record

ReviewAmerican journal of clinical dermatology2023

Cholinergic Urticaria: Subtype Classification and Clinical Approach.

Atsushi Fukunaga, Yoshiko Oda, Shinya Imamura, Mayuko Mizuno, Takeshi Fukumoto, Ken Washio

Open access · bronzeAbstract readReview
In one paragraph

Review in American journal of clinical dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Review
  3. Sweat components as a promising monitoring tool for systemic diseases.The journal of physiological sciences : JPS · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. New insights into chronic inducible urticaria.Current allergy and asthma reports · 2024
    Review
  10. Article
  11. Article
  12. Clozapine-induced cholinergic urticaria: a case report.Therapeutic advances in psychopharmacology · 2024
    Article
  13. Article
  14. The many faces of pediatric urticaria.Frontiers in allergy · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Atsushi FukunagaDivision of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan. atsushi.fukunaga@ompu.ac.jp.ORCID http://orcid.org/0000-0003-2026-8154
Yoshiko OdaDivision of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.ORCID http://orcid.org/0000-0002-5244-0871
Shinya ImamuraDivision of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.ORCID http://orcid.org/0000-0001-8670-4997
Mayuko MizunoDivision of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.ORCID http://orcid.org/0000-0002-8530-1720
Takeshi FukumotoDivision of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan.ORCID http://orcid.org/0000-0003-0364-711X
Ken WashioDepartment of Dermatology, Kobe City Nishi-Kobe Medical Center, 5-7-1 Koji-Dai Nishi-ku, Kobe, 651-2273, Japan.ORCID http://orcid.org/0000-0002-2468-7535
Kobe University · JPKobe City Nishi-Kobe Medical Center · JP

Funding

JSPS KAKENHI 20K08651
6 · The paper itself

Abstract

Cholinergic urticaria (CholU) is a subtype of chronic inducible urticaria with a chief complaint of itching and/or stinging, painful papular wheals that develop simultaneously with sweating. This review specifically focuses on several subtypes of CholU and specifically investigates the relationship between CholU and anhidrosis. We review recent publications and update the evidence around CholU, including the epidemiology, clinical features, diagnostic approaches, physiopathology, subtype classification, and therapeutic approaches. Multiple mechanisms contribute in a complex manner to the development of CholU, including histamine, sweat allergy, cholinergic-related substances, poral occlusion, and hypohidrosis/anhidrosis. A new schematic of the currently known pathological conditions has been created. Specific methods for diagnosing CholU, a provocation test, and evaluation methods for disease severity/activity and disease burden of CholU are summarized. The characteristics of the diseases that should be differentiated from CholU and examination methods are also summarized. The primary finding of this review is that CholU should be categorized based on the etiology and clinical characteristics of each subtype to properly manage and treat the disease. This categorization leads to improvement of therapeutic resistance status of this disease. In particular, a sweating abnormality should be given more attention when examining patients with CholU. Because CholU is not a homogeneous disease, its subtype classification is important for selection of the most suitable therapeutic method. Further elucidation of the pathophysiology of each subtype is expected.

Indexed as

HypohidrosisUrticariaCholinergic AgentsHumansSweatSweatingCholinergic Agents

Identifiers

PMID36107396
PMCPMC9476404
OpenAlexW4295898975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.